Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

SANUWAVE Health, Inc. (SNWV)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.05750.0000 (0.00%)
At close: 02:19PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0575
Open0.0500
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0500 - 0.0575
52 Week Range0.0001 - 0.1900
Volume152,957
Avg. Volume236,965
Market Cap31.552M
Beta (5Y Monthly)0.15
PE Ratio (TTM)N/A
EPS (TTM)-0.0510
Earnings DateAug 15, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for SNWV

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • SANUWAVE HEALTH INC
    ORGO: What does Argus have to say about ORGO?ORGANOGENESIS HOLDINGS INC has an Investment Rating of SELL; a target price of $3.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
  • GlobeNewswire

    SANUWAVE Announces Chief Financial Officer

    SANUWAVE Health, Inc. today announced the appointment of Dr. Toni Rinow as CFO Eden Prairie, MN, Aug. 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation wound care products, today announced the appointment of Dr. Toni Rinow, MBA as Chief Financial Officer (CFO). “With SEC filings current and recent financing finalized, bringing in a world-class CFO to build out the accounting and finance function is a strategic next step fo

  • GlobeNewswire

    SANUWAVE Health Reports Second Quarter 2022 Financial Results & Will Host Live Conference Call With Business Update

    Eden Prairie, MN, Aug. 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation wound care products, reported financial results for their second quarter ending June 30, 2022, with the SEC on Friday, August 12, 2022. The Company will host a live conference call on Tuesday, August 16, 2022, at 12:30 (EDT) to provide a business update (Dial-in information below). Quarter Highlights: Over 50 systems placed to treat wounds 100% increa

  • GlobeNewswire

    SANUWAVE Closes $12 Million Capital Raise

    SUWANEE, GA, Aug. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced the closing of its $12 million private placement. Use of proceeds is to expand production capacity to meet demand, pay off an existing debt facility, begin the NASDAQ up-listing process and for general working capital purposes. Kestrel Merchant Partners LLC acted as the exclusive sponsor and The Benchmark Co

Advertisement
Advertisement